{"id":263,"date":"2012-03-05T19:41:26","date_gmt":"2012-03-05T19:41:26","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=263"},"modified":"2026-02-25T20:44:13","modified_gmt":"2026-02-25T20:44:13","slug":"a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\/","title":{"rendered":"A role for XRCC2 gene polymorphisms in breast cancer risk and survival (Contributed by Dr Angela Cox)"},"content":{"rendered":"

Breast cancer can be caused by inherited changes in two major genes, BRCA1 and BRCA2, which can have devastating consequences, causing several cases of breast cancer in the same family. BRCA1 and BRCA2 code for proteins that are important for the repair of damaged DNA. In this study we have examined the effects of another gene, XRCC2, which is also involved in this same process. Whilst inherited variation in XRCC2 does not dramatically increase a woman\u2019s risk of breast cancer, we have some evidence that it may play a minor role in breast cancer risk and survival, and is worthy of further investigation. Understanding these genes with smaller effects, like XRCC2, may help us design better targetted treatments. (http:\/\/jmg.bmj.com\/content\/48\/7\/477<\/a> )<\/p>\n","protected":false},"excerpt":{"rendered":"

Breast cancer can be caused by inherited changes in two major genes, BRCA1 and BRCA2, which can have devastating consequences, causing several cases of breast cancer in the same family. BRCA1 and BRCA2 code for proteins that are important for the repair of damaged DNA. In this study we have examined the effects of another […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-263","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nA role for XRCC2 gene polymorphisms in breast cancer risk and survival (Contributed by Dr Angela Cox) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A role for XRCC2 gene polymorphisms in breast cancer risk and survival (Contributed by Dr Angela Cox) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"Breast cancer can be caused by inherited changes in two major genes, BRCA1 and BRCA2, which can have devastating consequences, causing several cases of breast cancer in the same family. BRCA1 and BRCA2 code for proteins that are important for the repair of damaged DNA. In this study we have examined the effects of another [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2012-03-05T19:41:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-25T20:44:13+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"A role for XRCC2 gene polymorphisms in breast cancer risk and survival (Contributed by Dr Angela Cox)\",\"datePublished\":\"2012-03-05T19:41:26+00:00\",\"dateModified\":\"2026-02-25T20:44:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\\\/\"},\"wordCount\":141,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\\\/\",\"name\":\"A role for XRCC2 gene polymorphisms in breast cancer risk and survival (Contributed by Dr Angela Cox) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2012-03-05T19:41:26+00:00\",\"dateModified\":\"2026-02-25T20:44:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2012\\\/03\\\/05\\\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A role for XRCC2 gene polymorphisms in breast cancer risk and survival (Contributed by Dr Angela Cox)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A role for XRCC2 gene polymorphisms in breast cancer risk and survival (Contributed by Dr Angela Cox) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\/","og_locale":"en_US","og_type":"article","og_title":"A role for XRCC2 gene polymorphisms in breast cancer risk and survival (Contributed by Dr Angela Cox) - JMG Contact blog","og_description":"Breast cancer can be caused by inherited changes in two major genes, BRCA1 and BRCA2, which can have devastating consequences, causing several cases of breast cancer in the same family. BRCA1 and BRCA2 code for proteins that are important for the repair of damaged DNA. In this study we have examined the effects of another [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\/","og_site_name":"JMG Contact blog","article_published_time":"2012-03-05T19:41:26+00:00","article_modified_time":"2026-02-25T20:44:13+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"A role for XRCC2 gene polymorphisms in breast cancer risk and survival (Contributed by Dr Angela Cox)","datePublished":"2012-03-05T19:41:26+00:00","dateModified":"2026-02-25T20:44:13+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\/"},"wordCount":141,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\/","url":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\/","name":"A role for XRCC2 gene polymorphisms in breast cancer risk and survival (Contributed by Dr Angela Cox) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2012-03-05T19:41:26+00:00","dateModified":"2026-02-25T20:44:13+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2012\/03\/05\/a-role-for-xrcc2-gene-polymorphisms-in-breast-cancer-risk-and-survival-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"A role for XRCC2 gene polymorphisms in breast cancer risk and survival (Contributed by Dr Angela Cox)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=263"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/263\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=263"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=263"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}